Verrica Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
15.12.23
/
50%
€5.10
Target price
15.12.24
€9.18
Performance (%)
33.33%
Price
06.05.24
€6.75
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Verrica Pharmaceuticals has seen massive gains of 33.33%. This prediction currently runs until 15.12.24. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | 3.610% | 3.610% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat